891 related articles for article (PubMed ID: 26199110)
1. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
2. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
3. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
[TBL] [Abstract][Full Text] [Related]
4. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
5. Blocking interferon γ reduces expression of chemokines CXCL9, CXCL10 and CXCL11 and decreases macrophage infiltration in ex vivo cultured arteries from patients with giant cell arteritis.
Corbera-Bellalta M; Planas-Rigol E; Lozano E; Terrades-García N; Alba MA; Prieto-González S; García-Martínez A; Albero R; Enjuanes A; Espígol-Frigolé G; Hernández-Rodríguez J; Roux-Lombard P; Ferlin WG; Dayer JM; Kosco-Vilbois MH; Cid MC
Ann Rheum Dis; 2016 Jun; 75(6):1177-86. PubMed ID: 26698852
[TBL] [Abstract][Full Text] [Related]
6. Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.
Ikeda A; Aoki N; Kido M; Iwamoto S; Nishiura H; Maruoka R; Chiba T; Watanabe N
Hepatology; 2014 Jul; 60(1):224-36. PubMed ID: 24700550
[TBL] [Abstract][Full Text] [Related]
7. Herpes Simplex Virus Type 2 Infection-Induced Expression of CXCR3 Ligands Promotes CD4
Zhang M; Deng X; Guan X; Geng L; Fu M; Zhang B; Chen R; Hu H; Hu K; Zhang D; Li M; Liu Y; Gong S; Hu Q
Front Immunol; 2018; 9():2932. PubMed ID: 30619292
[TBL] [Abstract][Full Text] [Related]
8. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
[TBL] [Abstract][Full Text] [Related]
9. CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.
Karin N
Front Immunol; 2020; 11():976. PubMed ID: 32547545
[TBL] [Abstract][Full Text] [Related]
10. Analysis of cysteine-X-cysteine motif chemokine ligands 9, 10, and 11, their receptor CXCR3, and their possible role on the recruitment of immune cells at the maternal-conceptus interface in pigs.
Han J; Gu MJ; Yoo I; Choi Y; Jang H; Kim M; Yun CH; Ka H
Biol Reprod; 2017 Jul; 97(1):69-80. PubMed ID: 28859287
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of the CXCR3 ligands in chronic hepatitis C virus (HCV) infection and their modulation by HCV in vitro.
Helbig KJ; Ruszkiewicz A; Lanford RE; Berzsenyi MD; Harley HA; McColl SR; Beard MR
J Virol; 2009 Jan; 83(2):836-46. PubMed ID: 18987152
[TBL] [Abstract][Full Text] [Related]
12. IL-18 enhances IFN-gamma-induced production of CXCL9, CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Shimizu T; Tada Y; Watanabe S
Eur J Immunol; 2007 Feb; 37(2):338-50. PubMed ID: 17274000
[TBL] [Abstract][Full Text] [Related]
13. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye.
Coursey TG; Bohat R; Barbosa FL; Pflugfelder SC; de Paiva CS
J Immunol; 2014 Nov; 193(10):5264-72. PubMed ID: 25288568
[TBL] [Abstract][Full Text] [Related]
14. Cross reactivity of three T cell attracting murine chemokines stimulating the CXC chemokine receptor CXCR3 and their induction in cultured cells and during allograft rejection.
Meyer M; Hensbergen PJ; van der Raaij-Helmer EM; Brandacher G; Margreiter R; Heufler C; Koch F; Narumi S; Werner ER; Colvin R; Luster AD; Tensen CP; Werner-Felmayer G
Eur J Immunol; 2001 Aug; 31(8):2521-7. PubMed ID: 11500837
[TBL] [Abstract][Full Text] [Related]
15. Liver inflammation in a mouse model of Th1 hepatitis despite the absence of invariant NKT cells or the Th1 chemokine receptors CXCR3 and CCR5.
Cripps JG; Celaj S; Burdick M; Strieter RM; Gorham JD
Lab Invest; 2012 Oct; 92(10):1461-71. PubMed ID: 22906987
[TBL] [Abstract][Full Text] [Related]
16. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
Müller M; Carter S; Hofer MJ; Campbell IL
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
[TBL] [Abstract][Full Text] [Related]
17. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
[TBL] [Abstract][Full Text] [Related]
18. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
Kanda N; Watanabe S
Endocrinology; 2007 May; 148(5):2317-25. PubMed ID: 17255201
[TBL] [Abstract][Full Text] [Related]
19. Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Wasmuth HE; Lammert F; Zaldivar MM; Weiskirchen R; Hellerbrand C; Scholten D; Berres ML; Zimmermann H; Streetz KL; Tacke F; Hillebrandt S; Schmitz P; Keppeler H; Berg T; Dahl E; Gassler N; Friedman SL; Trautwein C
Gastroenterology; 2009 Jul; 137(1):309-19, 319.e1-3. PubMed ID: 19344719
[TBL] [Abstract][Full Text] [Related]
20. CXCR3 and its ligands in a murine model of obliterative bronchiolitis: regulation and function.
Medoff BD; Wain JC; Seung E; Jackobek R; Means TK; Ginns LC; Farber JM; Luster AD
J Immunol; 2006 Jun; 176(11):7087-95. PubMed ID: 16709871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
